<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04247139</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00087964</org_study_id>
    <nct_id>NCT04247139</nct_id>
  </id_info>
  <brief_title>Kefir Cholesterol Lowering Pilot Study</brief_title>
  <official_title>Effect of Traditionally and Commercially Prepared Kefir on Cholesterol Levels in Adult Males With Borderline High Cholesterol Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High cholesterol (a type of fat in humans blood) may be one factor that can lead to heart&#xD;
      disease. If people have higher cholesterol, it is possible that kefir (a food similar to&#xD;
      yogurt) may help to control blood cholesterol levels.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New research shows that kefir (which contains bacteria also known as microbes), similar to&#xD;
      yogurt, may improve health by lowering cholesterol levels. Much of this research however,&#xD;
      focuses on traditional types of kefir, which differ significantly from commercially prepared&#xD;
      kefir with regards to the types of microbes in each kefir. Additionally, there is a lack of&#xD;
      research looking at how commercial kefir compares to traditional kefir in its ability to&#xD;
      improve health. This has led to the consumer being confused about the health benefits they&#xD;
      believe they are receiving, such as reduced weight gain, and improved cholesterol levels,&#xD;
      when they purchase and consume commercial kefir. The researchers have produced a commercially&#xD;
      usable kefir that has the health benefits of traditional grain fermented kefir. This was&#xD;
      accomplished with only a small subset of microbes present in the traditional kefir, leading&#xD;
      to a much easier product to commercialize and produce. Thus, this study aims to look at&#xD;
      whether kefir, produced in the researchers laboratory and commercially available kefir, given&#xD;
      to males for in two separate months, results in any cholesterol lowering effects. Successful&#xD;
      completion of this project could potentially result in the development of a new commercial&#xD;
      kefir with health benefits that are supported by scientific research and testing. In&#xD;
      addition, if positive results are seen, a larger study will be carried out to ensure that&#xD;
      results of the current study are consistent for the Canadian population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Both types of kefir will be flavoured the same, and visually look the same.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Blood Lipids following provision of each type of Kefir</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in blood lipid panel (HDL, LDL, Total Cholesterol, Triglycerides) will be measured in blood samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiota composition changes following the provision of each type Kefir</measure>
    <time_frame>4 weeks</time_frame>
    <description>16SrRNA-sequencing and whole metagenome sequencing will performed to determine gut microbial community changes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Commercial Kefir</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Commercially produced kefir</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional Kefir</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditionally grown kefir</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kefir</intervention_name>
    <description>commercial versus traditional kefir</description>
    <arm_group_label>Commercial Kefir</arm_group_label>
    <arm_group_label>Traditional Kefir</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males, aged 18-65y&#xD;
&#xD;
          2. Moderately hypercholesterolemic adults: LDL-C between 3.2 and 4.9 mM, but otherwise&#xD;
             healthy&#xD;
&#xD;
          3. No history of CVD, type 2 diabetes, monogenic dyslipidemia or use of medications for&#xD;
             hyperlipidemia (including statins).&#xD;
&#xD;
          4. No dairy allergy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male participants</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paulina Blanco Cervantes, MSc</last_name>
    <phone>780-492-9506</phone>
    <email>blancoce@ualberta.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Richard, PhD</last_name>
    <phone>780-248-1827</phone>
    <email>cr5@ualberta.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2E1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paulina Blanco Cervantes, MSc</last_name>
      <phone>780-492-9506</phone>
      <email>blancoce@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Benjamin Bourrie, PhD</last_name>
      <email>bourrie@ualberta.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin Willing, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline Richard, PhD, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>high cholesterol, kefir</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

